Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease.

Clinical journal of the American Society of Nephrology : CJASN

Volumn 1, Issue 6, 2006, Pages 1211-1215

  Macdougall, Iain C ^a   Robson, Richard ^a   Opatrna, Sylvie ^a   Liogier, Xavier ^a   Pannier, Anne ^a   Jordan, Paul ^a   Dougherty, Frank C ^a   Reigner, Bruno ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR; ERYTHROPOIETIN; MACROGOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEMOLYSIS; HUMAN; INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CROSS-OVER STUDIES; ERYTHROPOIETIN; FEMALE; HEMOLYSIS; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS;

EID: 33750973533     PISSN: None     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00730306     Document Type: Article

References (0)